156 related articles for article (PubMed ID: 8369576)
1. Short- and long-term considerations concerning the management of plaque psoriasis with low-dose cyclosporin. Studio Italiano Multicentrico nella Psoriasi (SIMPSO).
Dermatology; 1993; 187 Suppl 1():19-29. PubMed ID: 8369576
[TBL] [Abstract][Full Text] [Related]
2. Management of erythrodermic psoriasis with low-dose cyclosporin. Studio Italiano Multicentrico nella Psoriasi (SIMPSO).
Dermatology; 1993; 187 Suppl 1():30-7. PubMed ID: 8369577
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporin versus etretinate: Italian multicenter comparative trial in severe plaque-form psoriasis. Italian Multicenter Study Group on Cyclosporin in Psoriasis.
Dermatology; 1993; 187 Suppl 1():8-18. PubMed ID: 8369579
[TBL] [Abstract][Full Text] [Related]
4. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
Mahrle G; Schulze HJ; Färber L; Weidinger G; Steigleder GK
J Am Acad Dermatol; 1995 Jan; 32(1):78-88. PubMed ID: 7822521
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of oral cyclosporin A (CyA; Sandimmun) for long-term treatment of chronic severe plaque psoriasis.
Laburte C; Grossman R; Abi-Rached J; Abeywickrama KH; Dubertret L
Br J Dermatol; 1994 Mar; 130(3):366-75. PubMed ID: 8148280
[TBL] [Abstract][Full Text] [Related]
6. Intermittent cyclosporin A treatment of severe plaque psoriasis. Long-term follow-up of 26 patients.
Peluso AM; Bardazzi F; Tosti A; Varotti C
Acta Derm Venereol Suppl (Stockh); 1994; 186():90-1. PubMed ID: 8073851
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.
Ponticelli C; Edefonti A; Ghio L; Rizzoni G; Rinaldi S; Gusmano R; Lama G; Zacchello G; Confalonieri R; Altieri P
Nephrol Dial Transplant; 1993; 8(12):1326-32. PubMed ID: 8159300
[TBL] [Abstract][Full Text] [Related]
8. Remission of ordinary psoriasis following a short clearance course of cyclosporin.
Levell NJ; Shuster S; Munro CS; Friedmann PS
Acta Derm Venereol; 1995 Jan; 75(1):65-9. PubMed ID: 7747540
[TBL] [Abstract][Full Text] [Related]
9. Psoriasis relapse evaluation with week-end cyclosporine A treatment: results of a randomized, double-blind, multicenter study.
Colombo D; Cassano N; Altomare G; Giannetti A; Vena GA
Int J Immunopathol Pharmacol; 2010; 23(4):1143-52. PubMed ID: 21244763
[TBL] [Abstract][Full Text] [Related]
10. Body-weight-independent dosing of cyclosporine micro-emulsion and three times weekly maintenance regimen in severe psoriasis. A randomised study.
Thaçi D; Bräutigam M; Kaufmann R; Weidinger G; Paul C; Christophers E
Dermatology; 2002; 205(4):383-8. PubMed ID: 12444336
[TBL] [Abstract][Full Text] [Related]
11. Long-term continuous versus intermittent cyclosporin: therapy for psoriasis.
Ohtsuki M; Nakagawa H; Sugai J; Ozawa A; Ohkido M; Nakayama J; Hanada J; Morimoto Y; Jimbow K; Horikoshi T; Kitahara H; Tamaki K; Urabe K; Hori Y
J Dermatol; 2003 Apr; 30(4):290-8. PubMed ID: 12707465
[TBL] [Abstract][Full Text] [Related]
12. Intermittent short courses of cyclosporin (Neoral(R)) for psoriasis unresponsive to topical therapy: a 1-year multicentre, randomized study. The PISCES Study Group.
Ho VC; Griffiths CE; Albrecht G; Vanaclocha F; León-Dorantes G; Atakan N; Reitamo S; Ohannesson A; Mørk NJ; Clarke P; Pfister P; Paul C
Br J Dermatol; 1999 Aug; 141(2):283-91. PubMed ID: 10468801
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine as maintenance therapy in patients with severe psoriasis.
Shupack J; Abel E; Bauer E; Brown M; Drake L; Freinkel R; Guzzo C; Koo J; Levine N; Lowe N; McDonald C; Margolis D; Stiller M; Wintroub B; Bainbridge C; Evans S; Hilss S; Mietlowski W; Winslow C; Birnbaum JE
J Am Acad Dermatol; 1997 Mar; 36(3 Pt 1):423-32. PubMed ID: 9091474
[TBL] [Abstract][Full Text] [Related]
15. Short-term cyclosporin monotherapy for chronic severe plaque-type psoriasis.
Jan V; Vaillant L; Bressieux JM; Barthélemy H; Legoux A; Steiner HG; Reigneau O
Eur J Dermatol; 1999 Dec; 9(8):615-7. PubMed ID: 10586127
[TBL] [Abstract][Full Text] [Related]
16. Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: a 2-year cohort study.
Ho VC; Griffiths CE; Berth-Jones J; Papp KA; Vanaclocha F; Dauden E; Beard A; Puvanarajan L; Paul C
J Am Acad Dermatol; 2001 Apr; 44(4):643-51. PubMed ID: 11260540
[TBL] [Abstract][Full Text] [Related]
17. Quality of life improvement in treatment of psoriasis with intermittent short course cyclosporin (Neoral).
Salek MS; Finlay AY; Lewis JJ; Sumner MI
Qual Life Res; 2004 Feb; 13(1):91-5. PubMed ID: 15058791
[TBL] [Abstract][Full Text] [Related]
18. Low-dose (1.25 mg/kg) cyclosporin A: treatment of psoriasis and investigation of the influence on lipid profile.
Meffert H; Bräutigam M; Färber L; Weidinger G
Acta Derm Venereol; 1997 Mar; 77(2):137-41. PubMed ID: 9111826
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporin A treatment in severe childhood psoriasis.
Pereira TM; Vieira AP; Fernandes JC; Sousa-Basto A
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):651-6. PubMed ID: 16836490
[TBL] [Abstract][Full Text] [Related]
20. Long-term maintenance therapy with cyclosporine and posttreatment survey in severe psoriasis: results of a multicenter study. German Multicenter Study.
Mrowietz U; Färber L; Henneicke-von Zepelin HH; Bachmann H; Welzel D; Christophers E
J Am Acad Dermatol; 1995 Sep; 33(3):470-5. PubMed ID: 7657870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
